The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy

Safety And Efficacy ◽

Previously Treated

Faculty Opinions recommendation of The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164186.624873 ◽

2009 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

THU0202 Five-Year Safety and Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Despite Previous Anti-Tumor Necrosis Factor Therapy: Final Study Results of the Phase 3, Randomized, Placebo-Controlled Go-After Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.730 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A232.1-A232 ◽

Cited By ~ 2

Author(s):

J. S. Smolen ◽

J. Kay ◽

R. Landewé ◽

E. L. Matteson ◽

N. Gaylis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Phase 3 ◽

Safety And Efficacy ◽

Final Study ◽

Study Results ◽

Factor Therapy ◽

Necrosis Factor

Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.094375 ◽

2008 ◽

Vol 68 (7) ◽

pp. 1113-1118 ◽

Cited By ~ 14

Author(s):

D van der Heijde ◽

G Burmester ◽

J Melo-Gomes ◽

C Codreanu ◽

E M. Mola ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Radiographic Progression ◽

Previously Treated

Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

The Lancet ◽

10.1016/s0140-6736(18)31116-4 ◽

2018 ◽

Vol 391 (10139) ◽

pp. 2513-2524 ◽

Cited By ~ 119

Author(s):

Mark C Genovese ◽

Roy Fleischmann ◽

Bernard Combe ◽

Stephen Hall ◽

Andrea Rubbert-Roth ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Disease Modifying ◽

Randomised Controlled

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

10.1002/art.24567 ◽

2009 ◽

Vol 60 (7) ◽

pp. 1895-1905 ◽

Cited By ~ 373

Author(s):

Joel M. Kremer ◽

Bradley J. Bloom ◽

Ferdinand C. Breedveld ◽

John H. Coombs ◽

Mark P. Fletcher ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

The Safety and Efficacy of Etanercept on Cardiac Functions and Lipid Profile in Patients With Active Rheumatoid Arthritis

Journal of Investigative Medicine ◽

10.2310/jim.0b013e31823a00f4 ◽

2012 ◽

Vol 60 (1) ◽

pp. 62-65 ◽

Cited By ~ 2

Author(s):

Soner Senel ◽

Veli Cobankara ◽

Ozgur Taskoylu ◽

Ugur Karasu ◽

Hekim Karapinar ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Lipid Profile ◽

Safety And Efficacy ◽

Cardiac Functions

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

10.1002/art.34506 ◽

2012 ◽

Vol 64 (5) ◽

pp. 1487-1487 ◽

Cited By ~ 1

Author(s):

Joel M. Kremer ◽

Bradley J. Bloom ◽

Ferdinand C. Breedveld ◽

John H. Coombs ◽

Mark P. Fletcher ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial

Chinese Medical Journal ◽

10.1097/00029330-200804010-00008 ◽

2008 ◽

Vol 121 (7) ◽

pp. 615-619 ◽

Cited By ~ 17

Author(s):

Liang-jing LÜ ◽

Jia-lin TENG ◽

Chun-de BAO ◽

Xing-hai HAN ◽

Ling-yun SUN ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Multicenter Trial ◽

Double Blind ◽

Safety And Efficacy

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis

10.1002/art.1780401017 ◽

1997 ◽

Vol 40 (10) ◽

pp. 1838-1842 ◽

Cited By ~ 17

Author(s):

Dennis McGonagle ◽

Andrew Rawstron ◽

Stephen Richards ◽

John Isaacs ◽

Howard Bird ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Phase 1 ◽

Hematopoietic Progenitor Cells ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Hematopoietic Progenitor ◽

Phase 1 Study ◽

Safety And Efficacy ◽

Stimulating Factor

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis

10.1002/art.23059 ◽

2007 ◽

Vol 56 (12) ◽

pp. 3896-3908 ◽

Cited By ~ 228

Author(s):

Edward Keystone ◽

Roy Fleischmann ◽

Paul Emery ◽

Daniel E. Furst ◽

Ronald van Vollenhoven ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension ◽

Extension Analysis